US Stock MarketDetailed Quotes

SRZN Surrozen

Watchlist
  • 9.4050
  • +0.0750+0.80%
Close Apr 19 16:00 ET
  • 9.4900
  • +0.0850+0.90%
Post 16:02 ET
30.08MMarket Cap-440P/E (TTM)

About Surrozen Company

Surrozen, Inc. is a clinical stage biotechnology company. It engages in the business of discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. The company was founded by K. Christopher Garcia and Roeland Nusse on August 12, 2015 and is headquartered in South San Francisco, CA.

Company Profile

SymbolSRZN
Company NameSurrozen
Listing DateAug 12, 2021
Founded2015
CEOMr. Craig C. Parker
MarketNASDAQ
Employees42
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address171 Oyster Point Boulevard,Suite 400
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-650-489-9000
Websitehttp://www.surrozen.com

Company Executives

  • Name
  • Position
  • Salary
  • Craig C. Parker
  • President, Chief Executive Officer and Director
  • 1.17M
  • Charles Williams
  • Chief Operating Officer, Chief Financial Officer and Principal Accounting Officer
  • 675.53K
  • Dr. Yang Li, PhD
  • Executive Vice President, Research
  • 576.73K
  • Dr. David J. Woodhouse, PhD
  • Chairman of the Board
  • 73.05K
  • Eric H. Bjerkholt
  • Director
  • 56.94K
  • Dr. Shao-Lee Lin, M.D.,PhD
  • Independent Director
  • 48.05K
  • Dr. Anna Berkenblit, M.D.
  • Independent Director
  • 48.05K
  • Dr. Mary Haak-Frendscho, PhD
  • Independent Director
  • 53.05K
  • Christopher Y. Chai
  • Independent Director
  • 62.05K
  • Dr. Tim Kutzkey, PhD
  • Independent Director
  • 60.43K
  • Dr. Mace Rothenberg, M.D.
  • Independent Director
  • 47.05K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg